In vivo imaging for evaluating synaptic integrity;Le fonctionnement synaptique évalué par l'imagerie fonctionnelle du cerveau dans la maladie d'Alzheimer

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 3, Issue 2, 2005, Pages 97-106

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Activation; Alzheimer disease; Blood flow; Brain; Cytochrome oxidase; Energy; Glucose; Metabolism; Mitochondria; Neurofibrillary tangle; Oxidative phosphorylation; Positron emission tomography; Staging; Synapse

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; ASSOCIATION CORTEX; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE METABOLISM; HUMAN; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; GLUCOSE; HUMANS; NEUROFIBRILLARY TANGLES; OXIDATIVE PHOSPHORYLATION; POSITRON-EMISSION TOMOGRAPHY; SYNAPSES;

EID: 20444443545     PISSN: 17601703     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Sokoloff L. Relationship between functional activity and energy metabolism in the nervous system: whether, where and why? In: Lassen NA, Ingvar DH, Raichle ME, Friberg L, eds. Brain work and mental activity. Quantitative studies with radioactive tracers. Alfred Benzon Symposium VII. Copenhagen: Munksgaard, 1991: 52-67.
2. Folstein MF, Folstein SE, McHugh PR. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
3. Saunders AM. Gene identification in Alzheimer's disease. Pharmacogenomics 2001; 2: 239-49.
4. Davies CA, Mann DMA, Sumpter PQ, Yates PO. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 1987; 78: 151-64.
5. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 1988; 14: 177-95.
6. DeKosky ST, Scheff SW, Styren SD. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 1996; 5: 417-21.
7. Rapoport SI, Grady CL. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. Int J Neurosci 1993; 70: 39-56.
8. Hatanpää K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1996; 40: 411-20.
9. Hatanpää K, Isaacs KR, Shirao T, Brady DR, Rapoport SI. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999; 58: 637-43.
10. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298: 789-91.
11. Sato M, Kawarabayashi T, Shoji M, Kobayashi T, Tada N, Matsubara E, et al. Neurodegeneration and gliosis in transgenic mice overexpressing a carboxy-terminal fragment of Alzheimer amyloid-beta protein precursor. Dement Geriatr Cogn Disord 1997; 8: 296-307.
12. Rutten BP, Wirths O, Van de Berg WD, Lichtenthaler SF, Vehoff J, Steinbusch HW, et al. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiol Dis 2003; 12: 110-20.
13. Mattson MP, Gary DS, Chan SL, Duan W, Barger SW, Basile AS. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem Soc Symp 2001; 67: 151-62.
14. Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999; 24: 321-9.
15. Lehninger AL, Nelson DL, Cox MM. Principles of biochemistry. New York: Worth Press, 1993.
16. Wong-Riley MTT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989; 12: 94-101.
17. Hatanpää K, Chandrasekaran K, Brady DR, Rapoport SI. No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Brain Res Mol Brain Res 1998; 59: 13-21.
18. Nagy Z, Esiri MM, LeGris M, Matthews PM. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol (Berl) 1999; 97: 346-54.
19. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, et al. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 1997; 17: 7053-9.
20. Ricciardi E, Furey ML, Giovacchini G, Alexander GE, Schapiro MB, Rapoport SI, et al. Correlation between regional cerebral blood flow (rCBF) and glucose metabolism (rCMRglc) during rest and audiovisual stimulation is maintained in Alzheimer's disease. Soc Neurosci Abstr 2001; 27: 426-9.
21. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991; 4: 35-46.
22. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998; 50: 1585-93.
23. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res 1987; 407: 294-306.
24. Morrison JH, Hof PR, Campbell MJ, DeLima AD, Voigt T, Bouras C, et al. Cellular pathology in Alzheimer's disease: implications for corticocortical disconnection and differential vulnerability. In: Rapoport SI, Petit H, Leys D, Christen Y, eds. Imaging, cerebral topography and Alzheimer's disease, research and perspectives in Alzheimer's disease. Berlin: Fondation Ipsen, Springer-Verlag, 1990: 19-40.
25. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 1799-808.
26. DeCarli CS, Atack JR, Ball MJ, Kaye JA, Grady CL, Fewster P, et al. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1992; 1: 113-21.
27. Rapoport SI. Brain evolution and Alzheimer's disease. Rev Neurol (Paris) 1988; 144: 79-90.
28. Rapoport SI. Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain Res Rev 1990; 15: 267-94.
29. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993; 33: 403-8.
30. Luria AR. The working brain. An introduction to neuropsychology. New York: Basic Books, 1973.
31. Benton A. Visuoperceptual, visuospatial, and visuoconstructive disorders. In: Heilman KM, Valenstein E, eds. Clinical neuropsychology. (2d edition). New York: Oxford University Press, 1985: 151-85.
32. Grady CL, Haxby JV, Schapiro MB, Gonzalez-Aviles A, Kumar A, Ball MJ, et al. Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci 1990; 2: 373-84.
33. Grady CL, Sonies B, Haxby J, Luxenberg J, Friedland R, Rapoport S. Cerebral metabolic asymmetries predict decline in language performance in dementia of the Alzheimer type (DAT). J Clin Exp Neuropsychol 1988; 10: 39.
34. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990; 47: 753-60.
35. Haxby JV, Grady CL, Koss E, Horwitz B, Schapiro M, Friedland RP, et al. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 1988; 38: 1853-63.
36. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, et al. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988; 10: 576-96.
37. Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res 1995; 698: 223-6.
38. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, et al. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 1993; 13: 438-47.
39. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001; 12: 851-5.
40. Kennedy AM, Frackowiak RSJ, Newman SK, Bloomfield PM, Seaward J, Roques P, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995; 186: 17-20.
41. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273: 942-7.
42. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-8.
43. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-9.
44. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett 1997; 236: 21-4.
45. Grady CL, Haxby JV, Horwitz B, Gillette J, Salerno JA, Gonzalez-Aviles A, et al. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol Aging 1993; 14: 35-44.
46. Pietrini P, Furey ML, Alexander GE, Mentis MJ, Dani A, Guazzelli M, et al. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. Am J Psychiatry 1999; 156: 470-3.
47. VanMeter JW, Maisog JM, Zeffiro TA, Hallett M, Herscovitch P, Rapoport SI. Parametric analysis of functional neuroimages: application to a variable-rate motor task. Neuroimage 1995; 2: 373-83.
48. Mentis MJ, Horwitz B, Grady CL, Alexander GE, VanMeter JW, Maisog JM, et al. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am J Psychiatry 1996; 153: 32-40.
49. Mentis MJ, Alexander GE, Grady CL, Horwitz B, Krasuski J, Pietrini P, et al. Frequency variation of a pattern-flash visual stimulus during PET differentially activates brain from striate through frontal cortex. Neuroimage 1997; 5: 116-28.
50. Mentis MJ, Alexander GE, Krasuski J, Pietrini P, Furey ML, Schapiro MB, et al. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation. Am J Psychiatry 1998; 155: 785-94.
51. Grady CL. Age-related changes in cortical blood flow activation during perception and memory. Ann NY Acad Sci 1996; 777: 14-21.
52. Grady CL. Age-related differences in face processing: a meta-analysis of three functional neuroimaging experiments. Can J Exp Psychol 2002; 56: 208-20.
53. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000; 343: 450-6.
54. Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry 2002; 10: 44-51.
55. Furey ML, Pietrini P, Haxby JV, Alexander GE, Lee HC, Van Meter J, et al. Cholinergic stimulation alters performance and task specific regional cerebral blood flow during working memory. Proc Natl Acad Sci USA 1997; 94: 6512-6.
56. Purdon AD, Rapoport SI. Energy requirements for two aspects of phospholipid metabolism in mammalian brain. Biochem J 1998; 335: 313-8.
57. Rapoport SI. Deux stades, réversible et irréversible, de l'insuffisance fonctionnelle dans le cerveau Alzheimerien. In: Christien Y, ed. De la neurophysiologie à la maladie D'Alzheimer. Symposium en hommage à Yvon Lamour. Marseille: Solal, 1997: 165-72.
58. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Mark Rayport, traducteur. New York: Thieme Medical Publishers Inc, 1988.